期刊文献+

复方黄芪当归汤对MS大鼠胰岛素抵抗干预作用的研究 被引量:7

Intervention of Compound Huagnqi Danggui Prescription on Insulin Resistance of MS Rats
下载PDF
导出
摘要 目的:观察复方黄芪当归汤对MS大鼠胰岛素抵抗的干预影响以及在降糖、降脂和降压方面的功效,论证其在诊治MS方面的药用价值。方法:制备大鼠代谢综合征模型,观察正常对照组、模型组、预防组、中药治疗组以及西药对照组,观察用药前后各组FBG、TC、TG、HDL-C、LDL-C、FINS以及HOMA-IR指标水平。结果:(1)干预4周后,除预防组外各组大鼠的体重、TC、TG、FINS值均较正常对照组明显增加,差异显著(P<0.05)。同时,与模型组比较,预防组的TG值显著降低(P<0.05)。(2)干预8周后,与模型组比较,预防组和中药治疗组的FBG、TC和TG值显著降低(P<0.05);西药组SBP降低显著,预防组和治疗组的SBP略有降低,差异不显著。此外,预防组的HOMA-IR水平较模型组显著降低。结论:(1)复方黄芪当归汤能降低MS大鼠FBG、FINS及HOMA-IR水平,具有降低血糖、降低血清胰岛素以及改善MS大鼠的胰岛素敏感性等作用,在一定程度上可防止MS发生。(2)复方黄芪当归汤可显著降低MS大鼠的TC和TG值,能改善MS大鼠的血脂水平。 Objective: To observe the effect of Compound Huangqi Danggui Prescription on insulin resistance,diabetes,hyperlipidemia and hypertension in rats with MS and to demonstrate the medicinal value in terms of diagnosis and treatment of MS. Method: We established the model of rats with MS and observed the levels of FBG,TC,TG,HDL-C,LDL-C,FINS HOMA-IR before and after medicine in control group,model group,preventing group,traditional Chinese medicine group and western medicine group. Result:( 1) 4 weeks after the intervention,all rats' weights,levels of TC,TG and FINS significantly increased compared with those of the control group except preventing group and the difference was significant( P〈0. 05). On the other hand,compared with model group,TG was decreased significantly in preventing group( P〈0. 05).( 2) 8 weeks after the intervention,the levels of FBG,TC and TG in preventing group and TCM group were significantly decreased compared with those of the model group( P〈0. 05). SBP was significantly decreased in Western medicine group while the decreasing in preventing group and treatment group was slight with no significant difference. In addition,HOMA-IR in preventing group was significantly lower compared with that of the model group. Conclusion:( 1)Compound Huangqi Danggui Prescription can reduce levels of FBG,FINS and HOMA-IR and improve insulin sensitivity in rats with MS,and to a certain extent,can prevent the occurrence of MS.( 2) Compound Huangqi Danggui Prescription can significantly reduce levels of TC and TG in MS rats and improve blood lipid levels.
出处 《中华中医药学刊》 CAS 北大核心 2016年第6期1371-1374,共4页 Chinese Archives of Traditional Chinese Medicine
基金 浙江省中医药科学研究基金项目(2014ZB103)
关键词 代谢综合征 中药 胰岛素抵抗 metabolic syndrome traditional Chinese medicine insulin resistance
  • 相关文献

参考文献13

  • 1Eckel RH,Grundy SM,Zimmet PZ.The metabolic syndrome[J].Lancet,2005,365(9468):1415.
  • 2陈家伟.代谢综合征正在威胁人类健康[J].中华医学杂志,2004,84(7):529-530. 被引量:46
  • 3Reaven GM.Role of insulin resistance in human disease[J].Diabetes,1998,37(12):1595.
  • 4Jeffrey R,Shelling,John R.The metabolic syndrome as a risk factor for chronic kidney disease:more than a fat chance[J].J Am Soc Nephrology,2004,15(11):2773-2774.
  • 5Chen J,Muntner P,Hamm LL,et al.The metabolic syndrome and chronic kidney disease in US adults[J].Ann Intern Med,2004,140(3):167-174.
  • 6谌贻璞.代谢综合征相关肾损害[J].中华医学杂志,2006,86(30):2093-2094. 被引量:9
  • 7祝之明,徐成斌.应加强代谢综合征的研究和防治[J].中华心血管病杂志,2005,33(2):105-106. 被引量:62
  • 8仝小林,段军.代谢综合征的中医认识和治疗[J].中日友好医院学报,2002,16(5):347-348. 被引量:125
  • 9Eckardt KU,Coresh J,Devuyst O,et al.Evolving importance of kidney disease:from subspecialty to global health burden[J].Lancet,2013,382(9887):158-169.
  • 10Iseki K.Epidemiology of dyslipidemia in CKD[J].Nihon Jinzo Gakkai Shi,2013,55(7):1263-1266.

二级参考文献46

共引文献267

同被引文献139

  • 1黄水清,徐志伟.黄芪当归合剂黄芪当归调节血脂作用的研究进展[J].中医药学刊,2004,22(11):2020-2020. 被引量:9
  • 2纪立农.国际糖尿病联盟代谢综合征全球共识定义解读[J].中华糖尿病杂志(1006-6187),2005,13(3):175-177. 被引量:88
  • 3姚崇华,胡以松,翟凤英,杨晓光,孔灵芝,中国居民营养与健康状况调查技术执行组.我国2002年代谢综合征的流行情况[J].中国糖尿病杂志,2007,15(6):332-335. 被引量:135
  • 4汤小虎,邓中甲,唐辉.代谢综合征的中医认识及治疗[J].中医研究,2007,20(5):5-7. 被引量:27
  • 5Alfredo Halpern,Marcio C Mancini,Maria Eliane C Magalh,et al.Metabolic syndrome,dyslipidemia,hypertension and type 2 diabetes in youth:from diagnosis to treatment[J].Diabetol Metab Syndr,2010,2:55.
  • 6Bi H,Wu Y,Zhao C,Long G.Association between the dietary factors and metabolic syndrome with chronic kidney disease in Chinese adults[J].Int J Clin Exp Med,2014,7(11):4448-4454.
  • 7Fangfang Chen,Youfa Wang,Xiaoyi Shan,et.Association be tween Childhood Obesity and Metabolic Syndrome:Evidence from a Large Sample of Chinese Children and Adolescents[J].PLoS One,2012,7(10):e47380.
  • 8Michael E Hall,Jussara M do Carmo,Alexandre A da Silva,et.Obesity,hypertension,and chronic kidney disease[J].Int JNephrol Renovasc Dis,2014,7:75-88.
  • 9Roderick J.Tan,Youhua Liu.Matrix metalloproteinases in kid ney homeostasis and diseases[J].Am J Physiol Renal Physiol,2012,30201):F1351-F1361.
  • 10Peleg R,Treister-Goltzman Y.Isr Med Assoc J[J].Lancet,2015,17(11):726.

引证文献7

二级引证文献70

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部